DMO-transport in human red blood cells

Area of Science:

• Cellular biology
• Membrane transport
• Biochemistry

Background:

• Understanding the transport mechanisms of weak acids like 5,5-dimethyloxazolidine-2,4-dione (DMO) in human red blood cells is crucial for studying cellular pH regulation.
• Previous studies have investigated various solute transport systems, but the specific mechanism for DMO in erythrocytes requires further elucidation.

Purpose of the Study:

• To investigate the transport kinetics and mechanism of 5,5-dimethyloxazolidine-2,4-dione (DMO) in human red blood cells.
• To determine if DMO transport is mediated by specific transporters or occurs via passive diffusion.

Main Methods:

• Utilized radiolabeled 14C-DMO to measure unidirectional flux under self-exchange conditions at 0 degrees C in human red blood cells.
• Assessed the effect of varying DMO concentrations and extracellular pH on DMO transport rates.
• Tested the inhibitory effects of known anion transport inhibitors (DIDS, SITS, dipyridamole, phlorhizin, salicylate, butanol) on DMO flux.

Main Results:

• Unidirectional DMO flux demonstrated a linear relationship with DMO concentration up to approximately 100 mM.
• DMO flux significantly increased as the pH was reduced, indicating a pH-dependent transport process.
• DMO transport was not inhibited by a range of anion transport inhibitors, suggesting it does not utilize these pathways.
• A strong correlation was observed between unidirectional DMO flux and the concentration of the un-ionized form of DMO (DMOH).

Conclusions:

• The transport of 5,5-dimethyloxazolidine-2,4-dione (DMO) in human red blood cells is predominantly mediated by nonionic diffusion of its un-ionized form (DMOH).
• The permeability coefficient for DMOH was determined to be 9.5 x 10^-6 cm/s at 0 degrees C.
• DMO transport is independent of the classical anion exchange system in red blood cells.